Your browser doesn't support javascript.
loading
Landscape of somatic alterations in large-scale solid tumors from an Asian population.
Wu, Liqun; Yao, Herui; Chen, Hui; Wang, Aodi; Guo, Kun; Gou, Wenli; Yu, Yanfei; Li, Xiang; Yao, Ming; Yuan, Shaohua; Pang, Fei; Hu, Jinwei; Chen, Lijuan; Liu, Wenjin; Yao, Jicheng; Zhang, Shuirong; Dong, Xiaowei; Wang, Weifeng; Hu, Jing; Ling, Qi; Ding, Songming; Wei, Yan; Li, Qiang; Cao, Weichun; Wang, Shuang; Di, Yang; Feng, Feiling; Zhao, Gang; Zhang, Jian; Huang, Ling; Xu, Jia; Yan, Wangjun; Tong, Zhongsheng; Jiang, Da; Ji, Tao; Li, Qiao; Xu, Ling; He, Huiying; Shang, Liang; Liu, Jin; Wang, Kefeng; Wu, Duoguang; Shen, Jingnan; Liu, Ye; Zhang, Ting; Liang, Chaojie; Wang, Yusheng; Shang, Yanhong; Guo, Jianji; Liang, Guanbiao.
Afiliación
  • Wu L; Department of Hepatobiliary Surgery, Affiliated Hospital of Qingdao University, Qingdao, China.
  • Yao H; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Medical Oncology, Breast Tumor Center and Phase I Clinical Trial Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Chen H; Shanghai OrigiMed Co., Ltd, Shanghai, China.
  • Wang A; Shanghai OrigiMed Co., Ltd, Shanghai, China.
  • Guo K; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Gou W; Department of Obstetrics and Gynecology, First Affiliated Hospital of Xi'an Jiao Tong University, Xi'an, China.
  • Yu Y; Shanghai OrigiMed Co., Ltd, Shanghai, China.
  • Li X; Shanghai OrigiMed Co., Ltd, Shanghai, China.
  • Yao M; Shanghai OrigiMed Co., Ltd, Shanghai, China.
  • Yuan S; Shanghai OrigiMed Co., Ltd, Shanghai, China.
  • Pang F; Shanghai OrigiMed Co., Ltd, Shanghai, China.
  • Hu J; Shanghai OrigiMed Co., Ltd, Shanghai, China.
  • Chen L; Shanghai OrigiMed Co., Ltd, Shanghai, China.
  • Liu W; Shanghai OrigiMed Co., Ltd, Shanghai, China.
  • Yao J; Shanghai OrigiMed Co., Ltd, Shanghai, China.
  • Zhang S; Shanghai OrigiMed Co., Ltd, Shanghai, China.
  • Dong X; Shanghai OrigiMed Co., Ltd, Shanghai, China.
  • Wang W; Shanghai OrigiMed Co., Ltd, Shanghai, China.
  • Hu J; Department of Medical Oncology, The First People's Hospital of Yunnan Province, Kunming, China.
  • Ling Q; Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Ding S; Department of Hepatobiliary and Pancreatic Surgery, Shu Lan (Hangzhou) Hospital, Hangzhou, China.
  • Wei Y; Department of Oncology, Guigang City People's Hospital, The Eighth Affiliated Hospital of Guangxi Medical University, Guigang, China.
  • Li Q; Department of Hepatobiliary Surgery, Affiliated Hospital of North Sichuan Medical University, Nanchong, China.
  • Cao W; Department of Gynecologic Oncology, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
  • Wang S; Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
  • Di Y; Department of Pancreatic Surgery, Huashan Hospital, Fudan University, Shanghai, China.
  • Feng F; Department of Biliary Surgery, Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai, China.
  • Zhao G; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Zhang J; Department of General Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Huang L; Department of Gastrointestinal Oncology, Huifuxi Branch of Guangdong Provincial People's Hospital, Guangzhou, China.
  • Xu J; Department of Emergency, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Yan W; Department of Musculoskeletal Surgery, Shanghai Cancer Center, Fudan University, Shanghai, China.
  • Tong Z; Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Jiang D; Department of Oncology, Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Ji T; Musculoskeletal Tumor Center, Beijing Key Laboratory for Musculoskeletal Tumors, People's Hospital, Peking University, Beijing, China.
  • Li Q; National Cancer Center/ Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Xu L; Breast Disease Center, Peking University First Hospital, Beijing, China.
  • He H; Department of Pathology, School of Basic Medical Sciences, Third Hospital, Peking University, Beijing, China.
  • Shang L; Department of Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
  • Liu J; Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
  • Wang K; Department of Thoracic Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Wu D; Department of Thoracic Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Shen J; Department of Musculoskeletal Oncology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Liu Y; Department of Pathology, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China.
  • Zhang T; Department of Bone Marrow, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
  • Liang C; Department of General Surgery, The First Hospital of Shanxi Medical University, Taiyuan, China.
  • Wang Y; Department of Digestive, Shanxi Provincial Cancer Hospital, Taiyuan, China.
  • Shang Y; Department of Medical Oncology, The Affiliated Hospital, Hebei University, Baoding, China.
  • Guo J; Department of Thoracic Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Liang G; Department of Thoracic Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Nat Commun ; 13(1): 4264, 2022 07 23.
Article en En | MEDLINE | ID: mdl-35871175
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: China